Subscribe To
Astrazeneca reports positive results in prostate cancer trial, astrazeneca oncology unit evp says
David Fredrickson, executive vice-president for AstraZeneca's oncology business unit, discusses the fin...
February 15, 2022, 6:07 am
Eurodry ltd. (edry) ceo aristides pittas on q4 2021 results - earnings call transcript
EuroDry Ltd. (edrY) CEO Aristides Pittas on Q4 2021 Results - Earnings Call Transcript...
February 11, 2022, 5:09 am
Eurodry ltd. (edry) ceo aristides pittas on q4 2021 results - earnings call transcript
EuroDry Ltd. (edrY) CEO Aristides Pittas on Q4 2021 Results - Earnings Call Transcript...
February 11, 2022, 5:09 am
Eurodry ltd. (edry) ceo aristides pittas on q4 2021 results - earnings call transcript
EuroDry Ltd. (edrY) CEO Aristides Pittas on Q4 2021 Results - Earnings Call Transcript...
February 11, 2022, 5:09 am
Copa holdings, s.a. (cpa) ceo pedro heilbron on q4 2021 earnings call transcript
Copa Holdings, S.A. (CPA) CEO Pedro Heilbron on Q4 2021 Earnings Call Transcript...
February 10, 2022, 3:12 pm
Copa holdings, s.a. (cpa) ceo pedro heilbron on q4 2021 earnings call transcript
Copa Holdings, S.A. (CPA) CEO Pedro Heilbron on Q4 2021 Earnings Call Transcript...
February 10, 2022, 3:12 pm
Copa holdings, s.a. (cpa) ceo pedro heilbron on q4 2021 earnings call transcript
Copa Holdings, S.A. (CPA) CEO Pedro Heilbron on Q4 2021 Earnings Call Transcript...
February 10, 2022, 3:12 pm
Tui ag (tuiff) ceo friedrich joussen on q1 2022 results - earnings call transcript
TUI AG (TUIFF) CEO Friedrich Joussen on Q1 2022 Results - Earnings Call Transcript...
February 8, 2022, 4:59 pm
Tui ag (tuiff) ceo friedrich joussen on q1 2022 results - earnings call transcript
TUI AG (TUIFF) CEO Friedrich Joussen on Q1 2022 Results - Earnings Call Transcript...
February 8, 2022, 4:59 pm
Tui ag (tuiff) ceo friedrich joussen on q1 2022 results - earnings call transcript
TUI AG (TUIFF) CEO Friedrich Joussen on Q1 2022 Results - Earnings Call Transcript...
February 8, 2022, 4:59 pm
Eurodry ltd. sets date for the release of fourth quarter 2021 results, conference call and webcast
ATHENS, Greece, Feb. 04, 2022 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: edrY, the “Company” or “E...
February 4, 2022, 4:05 pm
Eurodry ltd. sets date for the release of fourth quarter 2021 results, conference call and webcast
ATHENS, Greece, Feb. 04, 2022 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: edrY, the “Company” or “E...
February 4, 2022, 4:05 pm
Eurodry ltd. sets date for the release of fourth quarter 2021 results, conference call and webcast
ATHENS, Greece, Feb. 04, 2022 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: edrY, the “Company” or “E...
February 4, 2022, 4:05 pm
Flora growth taps cannabis genetics and cultivation expert derek pedro as advisor
Marijuana company Flora Growth Corp. (NASDAQ:FLGC) announced Monday the appointment of world-renowned cannabis genetics and cultivation expert Derek P...
January 24, 2022, 9:00 am
Flora growth taps cannabis genetics and cultivation expert derek pedro as advisor
Marijuana company Flora Growth Corp. (NASDAQ:FLGC) announced Monday the appointment of world-renowned cannabis genetics and cultivation expert Derek P...
January 24, 2022, 9:00 am
Flora growth taps cannabis genetics and cultivation expert derek pedro as advisor
Marijuana company Flora Growth Corp. (NASDAQ:FLGC) announced Monday the appointment of world-renowned cannabis genetics and cultivation expert Derek P...
January 24, 2022, 9:00 am
Eurodry to acquire m/v molyvos luck vessel for $21.2m
EuroDry Ltd (NASDAQ: edrY) has agreed to acquire M/V Molyvos Luck, a drybulk vessel built-in 2014, fo...
January 19, 2022, 4:16 pm
Eurodry to acquire m/v molyvos luck vessel for $21.2m
EuroDry Ltd (NASDAQ: edrY) has agreed to acquire M/V Molyvos Luck, a drybulk vessel built-in 2014, fo...
January 19, 2022, 4:16 pm
Eurodry to acquire m/v molyvos luck vessel for $21.2m
EuroDry Ltd (NASDAQ: edrY) has agreed to acquire M/V Molyvos Luck, a drybulk vessel built-in 2014, fo...
January 19, 2022, 4:16 pm
Design therapeutics shares fall as goldman sachs initiates with sell rating
Goldman Sachs initiated coverage of Design Therapeutics Inc (NASDAQ: DSGN) with a Sell rating and a $10 price target. The analyst Madhu Kumar ha...
January 19, 2022, 12:51 pm